|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2010-3-16
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
The antiplatelet effects of the Platelet Inhibition and Patient Outcomes (PLATO) trial dose of ticagrelor in patients nonresponsive to clopidogrel and after they switch agents are unknown.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine,
http://linkedlifedata.com/resource/pubmed/chemical/Cell Adhesion Molecules,
http://linkedlifedata.com/resource/pubmed/chemical/Microfilament Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/P2RY12 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Purinergic P2 Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Purinergic P2Y12,
http://linkedlifedata.com/resource/pubmed/chemical/Ticagrelor,
http://linkedlifedata.com/resource/pubmed/chemical/Ticlopidine,
http://linkedlifedata.com/resource/pubmed/chemical/clopidogrel,
http://linkedlifedata.com/resource/pubmed/chemical/vasodilator-stimulated...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:AntoninoMark JMJ,
pubmed-author:BlidenKevin PKP,
pubmed-author:ButlerKathleenK,
pubmed-author:CheyneW WWW,
pubmed-author:EikelboomJohn WJW,
pubmed-author:GurbelPaul APA,
pubmed-author:HendersonDavidD,
pubmed-author:HustedSteenS,
pubmed-author:KereiakesDean JDJ,
pubmed-author:NielsenTonnyT,
pubmed-author:PatelDharmendra VDV,
pubmed-author:RasmussenLarsL,
pubmed-author:Sabe-AffakiGeorgesG,
pubmed-author:StoreyRobert FRF,
pubmed-author:TantryUdaya SUS,
pubmed-author:TengRenliR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
16
|
|
pubmed:volume |
121
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1188-99
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:20194878-Adenosine,
pubmed-meshheading:20194878-Aged,
pubmed-meshheading:20194878-Cell Adhesion Molecules,
pubmed-meshheading:20194878-Coronary Artery Disease,
pubmed-meshheading:20194878-Cross-Over Studies,
pubmed-meshheading:20194878-Double-Blind Method,
pubmed-meshheading:20194878-Female,
pubmed-meshheading:20194878-Flow Cytometry,
pubmed-meshheading:20194878-Humans,
pubmed-meshheading:20194878-Male,
pubmed-meshheading:20194878-Microfilament Proteins,
pubmed-meshheading:20194878-Middle Aged,
pubmed-meshheading:20194878-Phosphoproteins,
pubmed-meshheading:20194878-Phosphorylation,
pubmed-meshheading:20194878-Platelet Aggregation,
pubmed-meshheading:20194878-Platelet Aggregation Inhibitors,
pubmed-meshheading:20194878-Purinergic P2 Receptor Antagonists,
pubmed-meshheading:20194878-Receptors, Purinergic P2Y12,
pubmed-meshheading:20194878-Ticlopidine
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study.
|
|
pubmed:affiliation |
Sinai Center for Thrombosis Research, Cardiac Catheterization Laboratory, Baltimore, MD 21215, USA. pgurbel@lifebridgehealth.org
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
